» Articles » PMID: 26733937

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson's Disease Patients

Overview
Journal Front Neurol
Specialty Neurology
Date 2016 Jan 7
PMID 26733937
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Extracampine hallucinations (EH), the sense of a presence or fleeting movement in the absence of an associated visual percept, have been reported in Parkinson's disease (PD) patients but their prevalence, characteristics, and temporal relationship to visual hallucinations (VH) remain unclear. Given that, VH are predictive of cognitive impairment in PD, improved understanding of EH may have significant prognostic implications. The objective of this study is to evaluate the prevalence and characteristics of EH in a large unselected population with PD and to assess the temporal relationship between EH, VH, and memory decline. Cross-sectional data were collected from 414 PD patients using a questionnaire circulated via an online patient community. Data were obtained regarding the occurrence, timing, and characteristics of VH and EH and symptoms of PD, disease duration, disease severity, and medication history. About 50.4% of respondents reported EH and 15.5% reported VH. EH were typically experienced alongside, rather than behind, the individual (p < 0.001) without clear lateralization (p = 0.438) and were more likely to be of unfamiliar presences (p < 0.001). The occurrence of EH was associated with Hoehn and Yahr score (p = 0.002) but not disease duration (p = 0.158). EH onset was associated with VH onset (p = 0.046) and occurred after the onset of anosmia (p < 0.001), cognitive decline (p = 0.002), and sleep disturbance (p = 0.002). The reported prevalence of EH in PD patients was threefold greater than that of VH, with similar timings of onset, suggesting that EH are under-recognized and under-reported. Further work is needed to determine whether EH are predictive of cognitive decline.

Citing Articles

On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.

Pagan F, Schulz P, Torres-Yaghi Y, Pontone G CNS Drugs. 2024; 38(5):333-347.

PMID: 38587586 PMC: 11026222. DOI: 10.1007/s40263-024-01084-1.


Parkinson disease psychosis: from phenomenology to neurobiological mechanisms.

Pagonabarraga J, Bejr-Kasem H, Martinez-Horta S, Kulisevsky J Nat Rev Neurol. 2024; 20(3):135-150.

PMID: 38225264 DOI: 10.1038/s41582-023-00918-8.


Minor hallucinations in Parkinson's disease with probable rapid eye movement sleep behavior disorder.

Jiang Y, Zhu J, Zhao Y, Li D, Chen Y, Wang Y Front Neurosci. 2023; 17:1205439.

PMID: 37645371 PMC: 10461060. DOI: 10.3389/fnins.2023.1205439.


Phantom Boarder Relates to Experimentally-Induced Presence Hallucinations in Parkinson's Disease.

Blanke O, Bernasconi F, Potheegadoo J Mov Disord Clin Pract. 2023; 10(4):617-624.

PMID: 37070043 PMC: 10105112. DOI: 10.1002/mdc3.13684.


Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review.

Seritan A J Geriatr Psychiatry Neurol. 2023; 36(6):435-460.

PMID: 36941085 PMC: 10578041. DOI: 10.1177/08919887231164357.


References
1.
Pacchetti C, Manni R, Zangaglia R, Mancini F, Marchioni E, Tassorelli C . Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord. 2005; 20(11):1439-48. DOI: 10.1002/mds.20582. View

2.
Goetz C, Tanner C, Klawans H . Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry. 1982; 139(4):494-7. DOI: 10.1176/ajp.139.4.494. View

3.
Ibarretxe-Bilbao N, Junque C, Marti M, Tolosa E . Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies. J Neurol Sci. 2011; 310(1-2):79-81. DOI: 10.1016/j.jns.2011.06.019. View

4.
Solomonova E, Nielsen T, Stenstrom P, Simard V, Frantova E, Donderi D . Sensed presence as a correlate of sleep paralysis distress, social anxiety and waking state social imagery. Conscious Cogn. 2007; 17(1):49-63. DOI: 10.1016/j.concog.2007.04.007. View

5.
Hobson P, Meara J . Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord. 2004; 19(9):1043-9. DOI: 10.1002/mds.20216. View